The Development and Project Management team at Surrozen coordinates and oversees the progression of regenerative medicine projects from research and nonclinical development through clinical trials and regulatory approval. This team ensures seamless collaboration across departments, strategic project planning, regulatory compliance, and alignment with corporate objectives, enabling the efficient advancement of breakthrough therapies targeting the Wnt signaling pathway.